![Bob Ang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bob Ang
Direktor/Vorstandsmitglied bei
KOLON TISSUEGENE, INC.
Vermögen: 657 922 $ am 30.09.2024
Profil
Currently, Bob Ang is Director at Alliance for Regenerative Medicine since 2022 and Independent Director at Kolon TissueGene, Inc. Formerly, Dr. Ang was President, CEO, CFO, Director & CAO at Vor Biopharma, Inc. from 2019 to 2025; Director at Enara Bio Ltd.; Senior Associate at Frazier Management LLC from 2008 to 2009; Senior Vice President-Business Development at Bavarian Nordic, Inc. and Bavarian Nordic A from 2013 to 2015; Principal at The Boston Consulting Group, Inc. from 2000 to 2003; Vice President-Medical Affairs at Mallinckrodt Hospital Products, Inc.; Principal at Embark Healthcare; and Chief Business Officer at BioNTech US, Inc. from 2015 to 2019.
Education includes an MBA from Columbia Business School and a doctorate from The University of Western Australia conferred in 1998.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
Newfield Resources Ltd.
 Newfield Resources Ltd. Other Metals/MineralsNon-Energy Minerals Explores mineral properties 0,87 % | 15.11.2024 | 8.138.613 ( 0,87 % ) | 501 990 $ | 30.09.2024 |
VOR BIOPHARMA, INC. 0,02 % | 15.04.2026 | 8.470 ( 0,02 % ) | 155 933 $ | 30.06.2026 |
Aktive Positionen von Bob Ang
| Unternehmen | Position | Beginn |
|---|---|---|
| KOLON TISSUEGENE, INC. | Direktor/Vorstandsmitglied | - |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Direktor/Vorstandsmitglied | 01.01.2022 |
Ehemalige bekannte Positionen von Bob Ang
| Unternehmen | Position | Ende |
|---|---|---|
| VOR BIOPHARMA INC. | Vorstandsvorsitzender | 25.06.2025 |
| NEON THERAPEUTICS, INC. | Corporate Officer/Principal | 01.08.2019 |
Bavarian Nordic, Inc.
 Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and manufactures drugs to treat cancer | Corporate Officer/Principal | 01.01.2015 |
| BAVARIAN NORDIC A/S | Corporate Officer/Principal | 01.01.2015 |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical products & distribution, pharmaceuticals and healthcare service sectors. It provides financing for buyout and growth stage capital requirements. | Private-Equity-Analyst | 01.10.2009 |
Ausbildung von Bob Ang
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
75
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical products & distribution, pharmaceuticals and healthcare service sectors. It provides financing for buyout and growth stage capital requirements. | Finance |
Bavarian Nordic, Inc.
Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and manufactures drugs to treat cancer | Commercial Services |
Bavarian Nordic A/S
 Bavarian Nordic A/S BiotechnologyHealth Technology Engages in research, development and manufacturing travel vaccines | Health Technology |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Kolon TissueGene, Inc.
 Kolon TissueGene, Inc. Medical SpecialtiesHealth Technology Provides orthopedic therapeutic products | Health Technology |
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The University of Western Australia
 The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Embark Healthcare
 Embark Healthcare Investment ManagersFinance Embark Healthcare invests in companies located in the United States. The firm focuses on companies operating in the fields of healthcare industry. It provides financing for seed and early-stage capital requirements. | Finance |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioNTech US, Inc.
 BioNTech US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for cancer | Health Technology |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
Enara Bio Ltd.
 Enara Bio Ltd. BiotechnologyHealth Technology Develops cancer therapies | Health Technology |
